Home » Topics » BioWorld Science

BioWorld Science
RSS

SalioGen obtains funding to advance research into genetic therapy for cystic fibrosis

Jan. 7, 2022

Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206

Jan. 7, 2022

RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies

Jan. 7, 2022

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

Jan. 7, 2022

Discovery of novel bergenin derivatives as immunosuppressive agents

Jan. 7, 2022

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Jan. 7, 2022

Life Biosciences to accelerate R&D activities on aging-related programs

Jan. 7, 2022

Chinese researchers describe new GLP-1 receptor agonists

Jan. 7, 2022

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Jan. 7, 2022

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Jan. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...